S-BestAb
BMT Tandem Meetings Best Abstracts
BMT Tandem "Scientific" Meeting
Texas B+D (Gaylord Texan)
Chairs:
Paul J. Martin, MD
and
Ginna G. Laport, MD
Disclosures:
P. J. Martin,
Pfizer, DSMB Member: DSMB Member
Enlivex Therapeutics, Consultant for protocol: Consultancy
G. G. Laport,
Nothing To Disclose
CD4+ Invariant Natural Killer T Cells Protect from Acute Graft-Versus-Host Disease Lethality through a Dramatic Expansion of Donor-Derived CD4+FoxP3+ Regulatory T Cells
Dominik Schneidawind, MD, Stanford University;
Antonio Pierini, MD, Stanford University;
Maite Alvarez, PhD, Stanford University;
Yuqiong Pan, MD, PhD, Stanford University;
Jeanette Baker, PhD, Stanford University;
Byung Su Kim, MD, Stanford University;
Hidekazu Nishikii, MD, PhD, Stanford University;
Corina Büchele, MD, Stanford University;
Everett Meyer, MD, PhD, Stanford University Medical Center;
Robert Negrin, MD, Stanford University Medical Center
ATG16L1 Prevents Lethal T-Cell Alloreactivity Mediated By Dendritic Cells
Yusuke Shono, MD, PhD, Memorial Sloan-Kettering Cancer Center;
Vanessa Hubbard-Lucey, PhD, Skirball Institute, New York University School of Medicine;
Katie Maurer, Skirball Institute, New York University School of Medicine;
Anne Mary Dickinson, BSc, PhD, Institute of Cellular Medicine;
Ernst Holler, MD, PhD, University of Regensburg Medical Center;
Kenneth H Cadwell, PhD, Skirball Institute, New York University School of Medicine;
Marcel R. M. van den Brink, MD, PhD, Memorial Sloan-Kettering Cancer Center
Retrospective Study of 240 Patients with Severe Combined Immunodeficiency Transplanted from 2000-2009: A Report from the Primary Immune Deficiency Treatment Consortium of North America
Sung-Yun Pai, MD, Boston Children's Hospital;
Brent R. Logan, PhD, Medical College of Wisconsin;
Linda M Griffith, MD, PhD, DAIT, NIAID, NIH;
Rebecca H Buckley, MD, Duke University Medical Center;
Roberta E Parrott, BS, Duke University Medical Center;
Christopher C. Dvorak, MD, University of California San Francisco Medical Center;
Neena Kapoor, MD, Children's Hospital Los Angeles;
Imelda C Hanson, MD, Baylor College of Medicine, Texas Children's Hospital;
Alexandra Filipovich, MD, Cincinnati Children's Hospital Medical Center;
Soma Jyonouchi, MD, Children's Hospital of Philadelphia;
Trudy Small, MD, Memorial Sloan-Kettering Cancer Center;
Lauri Burroughs, MD, Fred Hutchinson Cancer Research Center;
Ann E Haight, MD, Emory / Children's Healthcare of Atlanta;
Michael A. Pulsipher, MD, Primary Children's Medical Center, University of Utah School of Medicine;
Ka Wah Chan, MD, Texas Transplant Institute;
Ramsay Fuleihan, MD, Ann & Robert H. Lurie Children's Hospital of Chicago;
Elie Haddad, MD PhD, Ste-Justine Hospital;
Brett Loechelt, MD, Children's National Medical Center;
Victor Aquino, MD, University of Texas Southwestern Medical Center;
Alfred P. Gillio, MD, HUMC;
Jeffrey H Davis, MD, British Columbia Children's Hospital;
Alan Knutsen, MD, Cardinal Glennon Children's Medical Center;
Angela Smith, MD, MS, University of Minnesota Medical Center, Fairview;
Theodore B Moore, MD, David Geffen School of Medicine at UCLA;
Marlis Schroeder, MD, CancerCare Manitoba;
Frederick Goldman, MD, The University of Alabama at Birmingham;
James A Connelly, MD, University of Michigan;
Matthew H. Porteus, MD, Stanford University;
Qun Xiang, MS, Medical College of Wisconsin;
William Shearer, MD, PhD, Baylor College of Medicine, Texas Children's Hospital;
Thomas Fleisher, MD, National Institutes of Health;
Donald B. Kohn, MD, University of California, Los Angeles;
Jennifer Puck, MD, UCSF Benioff Children's Hospital;
Luigi D. Notarangelo, MD, Children’s Hospital Boston, Harvard Medical School;
Morton J Cowan, MD, UCSF Benioff Children's Hospital;
Richard O'Reilly, MD, Memorial Sloan-Kettering Cancer Center
HLA-Mismatch Is Associated with Worse Outcomes after Myeloablative Conditioning and Unrelated Donor Hematopoietic Cell Transplantation: A Cibmtr Analysis
Joseph Pidala, MD, MS, H. Lee Moffitt Cancer Center and Research Institute;
Stephanie J. Lee, MD, MPH, Fred Hutchinson Cancer Research Center;
Stephen R Spellman, MBS, Center for International Blood and Marrow Transplant Research;
Hailin Wang, MPH, Medical College of Wisconsin;
Kwang Woo Ahn, PhD, Medical College of Wisconsin;
Mahmoud D. Aljurf, MD, MPH, King Faisal Specialist Hospital and Research Centre;
Medhat Askar, MD, PhD, Cleveland Clinic;
Jason Dehn, MPH, National Marrow Donor Program;
Marcelo A. Fernandez Viña, PhD, Stanford Hospital and Clinics;
Alois Gratwohl, MD, University Hospital Basel;
Vikas Gupta, MD, Princess Margaret Cancer Center, University of Toronto;
Rabi Hanna, MD, Cleveland Clinic;
Carolyn K. Hurley, PhD, Georgetown University Hospital;
Yoshihiro Inamoto, MD, Fred Hutchinson Cancer Research Center;
Adetola A. Kassim, MD, MS, Vanderbilt University Medical Center;
Taiga Nishihori, MD, H. Lee Moffitt Cancer Center and Research Institute;
Machteld Oudshoorn, PhD, Leiden University Medical Centre;
Effie W. Petersdorf, MD, Fred Hutchinson Cancer Research Center;
Vinod K. Prasad, MD, Duke University Medical Center;
Wael Saber, MD, MS, Medical College of Wisconsin;
Kirk R. Schultz, MD, British Columbia's Children's Hospital;
William A. Wood, MD, MPH, University of North Carolina Hospitals;
Jan Storek, MD, PhD, Tom Baker Cancer Centre/Foothills Hospital;
Ann E. Woolfrey, MD, Fred Hutchinson Cancer Research Center;
Claudio Anasetti, MD, H. Lee Moffitt Cancer Center and Research Institute
Clinical Responses in Patients Infused with T Lymphocytes Redirected to Target Kappa-Light Immunoglobulin Chain
Carlos A. Ramos, MD, Baylor College of Medicine, Houston Methodist Hospital and Texas Children's Hospital;
Barbara Savoldo, MD, PhD, Texas Children's Hospital;
Enli Liu, Baylor College of Medicine;
Adrian P. Gee, PhD, Baylor College of Medicine, Houston Methodist Hospital and Texas Children's Hospital;
Zhuyong Mei, MD, Baylor College of Medicine;
Bambi Grilley, RPh, Baylor College of Medicine;
Cliona M. Rooney, PhD, Baylor College of Medicine;
Helen E. Heslop, MD, Baylor College of Medicine;
Malcolm K. Brenner, MD, PhD, Baylor College of Medicine;
Gianpietro Dotti, MD, Baylor College of Medicine
